Now entering its ninth year, IBC's Formulation Strategies for Protein Therapeutics presents a unique combination of cutting edge science, best practices and responses to regulatory challenges. The topics presented in this meeting are determined through the input of formulation scientists like you who are also working to overcome the challenges of advanced protein therapeutics and next-generation delivery methods - offering you strategies you can apply right away to your day to day work.

Visit us in booth #923

Don’t miss this special session:
A faster, more reliable route to a robust formulation using microscale, parallel experimentation
Byeong S. Chang, Ph.D., Symyx Technologies, Inc.

Delivering drug product with a highly optimized and robust formulation is essential to ensure the clinical trial tests the efficacy of the drug – not the limitations of the formulation.
Symyx, a pioneer in applying high-throughput technology to life-science drug development, presents a novel research workflow that systematically screens a large variable space to identify and develop highly optimized formulations using minimal quantities of drug substance. We will present three case studies illustrating development with this workflow.

For more information about the meeting visit: http://www.ibclifesciences.com/formulation/overview.xml